首页> 外文期刊>The British journal of cancer >Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
【24h】

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

机译:在血清外泌体中鉴定真正的microRNA生物标志物,该血清外泌体预测肝移植后肝细胞癌复发

获取原文
获取原文并翻译 | 示例
           

摘要

Background Predictive biomarkers for the recurrence of hepatocellular carcinoma (HCC) have great benefit in the selection of treatment options, including liver transplantation (LT), for HCC. The purpose of this study was to identify specific microRNAs (miRs) in exosomes from the serum of patients with recurrent HCC and to validate these molecules as novel biomarkers for HCC recurrence.
机译:肝细胞癌(HCC)复发的背景预测生物标志物在选择治疗方案(包括肝移植(LT))的HCC中具有很大的好处。 这项研究的目的是鉴定来自复发性HCC患者血清血清中外泌体中的特定microRNA(miR),并验证这些分子作为HCC复发的新生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号